Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1214717 BOSTON, MA

Position in XENE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$82,700,080
+$19,146,086 QoQ
Shares Held
1,370,114
+25.4% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 314 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. XENE ranks #57 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XENE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $82,700,080 1,370,114
2026-03-31 $63,553,994 1,092,932
2025-12-31 $42,699,072 952,679
2025-09-30 $39,244,014 977,435
2025-06-30 $30,371,735 970,343
2025-03-31 $2,334,979 69,597
2024-12-31 $2,725,536 69,529
2024-09-30 $2,709,010 68,809
2024-06-30 $2,687,541 68,929
2024-03-31 $2,765,058 64,229
2023-12-31 $2,859,082 62,073
2023-09-30 $1,911,081 55,945
2023-06-30 $2,152,727 55,915
2023-03-31 $1,994,397 55,725
2022-12-31 $2,179,887 55,285
2022-09-30 $2,231,810 61,823
2022-06-30 $1,384,596 45,516
2022-03-31 $862,012 28,198
2021-12-31 $880,905 28,198
2021-09-30 $330,812 21,650
2021-06-30 $403,123 21,650
2021-03-31 $344,431 19,242
2020-12-31 $295,941 19,242
2020-09-30 $213,008 19,242
2020-06-30 $241,294 19,242
2020-03-31 $218,204 19,242